Prospective study of offspring of Caribbean patients with type 2 diabetes: Results of a 1-year follow-up study

Canadian Journal of Diabetes

Volumn 27, Issue 3, 2003, Pages 248-255

  Ezenwaka, Chidum E ^a  

^a UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE; MALE; MODEL; NON INSULIN DEPENDENT DIABETES MELLITUS; PROGENY; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0141516178     PISSN: 14992671     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Eriksson J, Franssila-Kallunki A, Ekstrand A, et al. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med. 1989;321:337-343.
2. Warram JH, Martin BC, Krolewski AS, et al. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med. 1990;113:909-915.
3. Haffner SM, Stern MP, Hazuda HP, et al. Increased insulin concentrations in nondiabetic offspring of diabetic parents. N Engl J Med. 1988;319:1297-1301.
4. Osei K. Increased basal glucose production and utilization in nondiabetic first-degree relatives of patients with NIDDM. Diabetes. 1990;39:597-601.
5. Osei K, Cottrell DA, Adenuwon CA, et al. Serum insulin and glucose concentrations in people at risk for type II diabetes. A comparative study of African Americans and Nigerians. Diabetes Care. 1993;16:1367-1375.
6. Snehalatha C, Ramachandran A, Satyavani K, et al. Study of genetic prediabetic south Indian subjects. Importance of hyperinsulinemia and beta-cell dysfunction. Diabetes Care. 1998;21:76-79.
7. Ezenwaka CE, Akanji AO, Osei K, et al. Glucose and insulin responses to intravenous glucose challenge in relatives of Nigerian patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract. 1993;20:175-181.
8. Ezenwaka CE, Davis G, Offiah NV. Insulin secretion in glucose-tolerant offspring of type 2 diabetes patients in Trinidad, West Indies. South Med J. 2001;94:223-228.
9. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
10. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173-194.
11. Zavaroni I, Bonini L, Fantuzzi M, et al. Hyperinsulinaemia, obesity, and syndrome X. J Intern Med. 1994;235:51-56.
12. Gaillard TR, Schuster DP, Bossetti BM, et al. The impact of socioeconomic status on cardiovascular risk factors in African-Americans at high risk for type II diabetes. Implications for syndrome X. Diabetes Care. 1997;20:745-752.
13. Stewart MW, Humphriss DB, Berrish TS, et al. Features of syndrome X in first-degree relatives of NIDDM patients. Diabetes Care. 1995;18:1020-1022.
14. Ezenwaka CE, Davis G, Offiah NV. Evaluation of features of syndrome X in offspring of Caribbean patients with type 2 diabetes. Scand J Clin Lab Invest. 2001;61:19-26.
15. Central Statistical Office, Republic of Trinidad and Tobago. Population and Housing Census.Vol.II:Age, Structure, Religion, Ethnic Group, Education. Port of Spain, Trinidad and Tobago, West Indies: Central Statistical Office; 1994.
16. Miller GJ, Maude GH, Beckles GLA. Incidence of hypertension and non-insulin dependent diabetes mellitus and associated risk factors in a rapidly developing Caribbean community: the St James survey, Trinidad. J Epidemiol Community Health. 1996;50:497-504.
17. Gulliford MC. Epidemiological transition in Trinidad and Tobago, West Indies 1953-1992. Int J Epidemiol. 1996;25:357-365.
18. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med. 1997;14(suppl 5):S1-S85.
19. Ezenwaka CE, Davis G. Increased risk of cardiovascular disease in newly diagnosed type 2 diabetic patients in a primary health care center in Trinidad. Diabetes Res Clin Pract. 2000;50:137-145.
20. Wolever T, Ramdath D. The use of Caribbean foods in the management of diabetes mellitus. West Indian Med J. 1997;46(suppl 1):21-23.
21. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
22. Turner RC, Holman RR, Matthews D, et al. Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. Metabolism. 1979;28:1086-1096.
23. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.
24. Zimmet PZ, Collins VR, Dowse GK, et al. The relation of physical activity to cardiovascular disease risk factors in Mauritians. Mauritius Noncommunicable Disease Study Group. Am J Epidemiol. 1991;134:862-875.
25. Tuomilehto J, Lindström J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343-1350.
26. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
27. Zavaroni I, Dall'Aglio E, Alpi O, et al. Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride. Atherosclerosis. 1985;55:259-266.
28. Haffner SM, Fong D, Hazuda HP, et al. Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non-diabetics. Metabolism. 1988;37:338-345.
29. Stern MP, Haffner SM. Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular disease. Arteriosclerosis. 1986;6:123-130.
30. Cullen K, Stenhouse NS, Wearne KL, et al. Multiple regression analysis of risk factors for cardiovascular disease and cancer mortality in Busselton, Western Australia: 13-year study. J Chronic Dis. 1983;36:371-377.
31. Anderson KM, Castelli WP, Levy D. Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA. 1987;257:2176-2180.
32. Grundy SM. Cholesterol and coronary heart disease. A new era. JAMA. 1986;256:2849-2858.
33. Levy RI. Primary prevention of coronary heart disease by lowering lipids: results and implications. Am Heart J. 1985;110:1116-1122.
34. DeFronzo RA, Simonson D, Ferrannini E. Hepatic and peripheral insulin resistance: a common feature of type 2 (noninsulin-dependent) and type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1982;23:313-319.
35. Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23:57-63.